Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - QUIDEL CORP /DE/ | d311270d8k.htm |
| EX-10.1 - 2012 CASH INCENTIVE COMPENSATION PLAN - QUIDEL CORP /DE/ | d311270dex101.htm |
| EX-10.2 - 2012 EMPLOYEE DEFERRED BONUS COMPENSATION PROGRAM - QUIDEL CORP /DE/ | d311270dex102.htm |
| EX-10.3 - 2012 EQUITY INCENTIVE PLAN GRANTS TO THE COMPANY'S EXECUTIVE OFFICERS - QUIDEL CORP /DE/ | d311270dex103.htm |
Exhibit 10.4
2012 Annual Base Salaries
| Executive Officer |
Prior Base Salary | 2012 Base Salary | ||||||
| Douglas C. Bryant President and Chief Executive Officer |
$ | 482,040 | $ | 496,501 | ||||
| Robert J. Bujarski Senior Vice President, Business Development and General Counsel |
$ | 311,472 | $ | 320,816 | ||||
| Scot M. McLeod Senior Vice President, Operations |
$ | 276,841 | $ | 285,146 | ||||
| Mark Smits Senior Vice President, Commercial Operations, North America |
$ | 285,000 | $ | 290,700 | * | |||
| Timothy T. Stenzel Chief Scientific Officer |
$ | 299,421 | $ | 308,404 | ||||
| Randall Steward Chief Financial Officer |
$ | 300,000 | $ | 303,000 | * | |||
| John D. Tamerius Senior Vice President, Clinical and Regulatory Affairs |
$ | 281,726 | $ | 290,178 | ||||
| * | Prorated salary increase for those hired by the Company in calendar year 2011. |